Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 2.64 M2.6 M2.6 M2.43 M2.46 M2.36 M 9.86 M Research & development —————— — Operating income -6.42 M-10.89 M-86.99 M1.17 M15.94 M17 M -52.88 M Non-Operating Income, Total -14 K-10 K0-409 K-50 K-77 K -536 K Interest expense, net of interest capitalized 32.24 M32.08 M31.26 M30.75 M31.59 M29 M 122.61 M Non-Operating Income, excl. Interest Expenses -32.25 M-32.09 M-31.26 M-31.16 M-31.64 M-29.08 M -123.14 M Unusual income/expense —————— — Pretax income -7.99 M-9.48 M-54.01 M2.92 M3.54 M4.34 M -43.2 M Equity in earnings —————— — Taxes -1.82 M-2.18 M-9.01 M469 K800 K913 K -6.83 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -6.17 M-7.3 M-45 M2.45 M2.74 M3.43 M -36.38 M Discontinued operations —————— — Net income -6.17 M-7.3 M-45 M2.45 M2.74 M3.43 M -36.38 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -6.75 M-7.88 M-45.59 M1.87 M2.16 M2.85 M -38.71 M Basic earnings per share (Basic EPS) -0.54-0.61-3.01-0.010.140.17 -2.71 Diluted earnings per share (Diluted EPS) -0.54-0.61-3.010.130.140.17 -2.57 Average basic shares outstanding 12.51 M12.91 M15.12 M13.99 M15.8 M16.33 M — Diluted shares outstanding 12.51 M12.91 M15.12 M13.99 M15.8 M16.33 M — EBITDA -40.81 M-44.2 M-119.48 M-30.13 M-17.52 M-13.51 M -180.64 M EBIT -39.41 M-43.52 M-118.9 M-30.39 M-16.41 M-12.51 M -178.21 M Cost of revenue 14.55 M16.61 M47.93 M2.64 M2.63 M2.63 M 55.82 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) -1.43 M-675 K-581 K260 K-1.11 M-995 K -2.43 M